Induction of Cullin 7 by DNA damage attenuates p53 function

被引:29
作者
Jung, Peter
Verdoodt, Berlinda
Bailey, Aaron
Yates, John R., III
Menssen, Antje
Hermeking, Heiko
机构
[1] Max Planck Inst Biochem, D-82152 Martinsried, Germany
[2] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA
关键词
cu17; fbx29; cell cycle; p21; tumor suppression;
D O I
10.1073/pnas.0609467104
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The p53 tumor suppressor gene encodes a transcription factor, which is translationally and posttranslationally activated after DNA damage. In a proteornic screen for p53 interactors, we found that the cullin protein Cu17 efficiently associates with p53. After DNA damage, the level of CUP protein increased in a caffeinesensitive, but p53-independent, manner. Down-regulation of Cu17 by conditional microRNA expression augmented p53-mediated inhibition of cell cycle progression. Ectopic expression of Cu17 inhibited activation of p53 by DNA damaging agents and sensitized cells to adriamycin. Although CuP recruited the F-box protein FBX29 to p53, the combined expression of Cul7/FBX29 did not promote ubiquitination and degradation of p53 in vivo. Therefore, the inhibition of p53 activity by Cu17 is presumably mediated by alternative mechanisms. The interplay between p53 and Cu17 resembles the negative feedback loop described for p53 and Mdm2. Pharmacological modulation of Cu17 function may allow the sensitization of cancer cells expressing wild-type p53 to genotoxic agents used in cancer therapy.
引用
收藏
页码:11388 / 11393
页数:6
相关论文
共 39 条
[1]   Cu17/p185/p193 binding to simian virus 40 large T antigen has a role in cellular transformation [J].
Ali, SH ;
Kasper, JS ;
Arai, T ;
DeCaprio, JA .
JOURNAL OF VIROLOGY, 2004, 78 (06) :2749-2757
[2]   Cytoplasmic localized ubiquitin ligase cullin 7 binds to p53 and promotes cell growth by antagonizing p53 function [J].
Andrews, P. ;
He, Y. J. ;
Xiong, Y. .
ONCOGENE, 2006, 25 (33) :4534-4548
[3]   Targeted disruption of p185/Cul7 gene results in abnormal vascular morphogenesis [J].
Arai, T ;
Kasper, JS ;
Skaar, JR ;
Ali, SH ;
Takahashi, C ;
DeCaprio, JA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (17) :9855-9860
[4]   MDM2 EXPRESSION IS INDUCED BY WILD TYPE-P53 ACTIVITY [J].
BARAK, Y ;
JUVEN, T ;
HAFFNER, R ;
OREN, M .
EMBO JOURNAL, 1993, 12 (02) :461-468
[5]   Post-translational modification of p53 in tumorigenesis [J].
Bode, AM ;
Dong, ZG .
NATURE REVIEWS CANCER, 2004, 4 (10) :793-805
[6]   Stringent doxycycline-dependent control of gene activities using an episomal one-vector system -: art. no. e137 [J].
Bornkamm, GW ;
Berens, C ;
Kuklik-Roos, C ;
Bechet, JM ;
Laux, G ;
Bachl, J ;
Korndoerfer, M ;
Schlee, M ;
Hölzel, M ;
Malamoussi, A ;
Chapman, RD ;
Nimmerjahn, F ;
Mautner, J ;
Hillen, W ;
Bujard, H ;
Feuillard, J .
NUCLEIC ACIDS RESEARCH, 2005, 33 (16) :1-11
[7]   p53 ubiquitination: Mdm2 and beyond [J].
Brooks, CL ;
Gu, W .
MOLECULAR CELL, 2006, 21 (03) :307-315
[8]   Disruption of p53 in human cancer cells alters the responses to therapeutic agents [J].
Bunz, F ;
Hwang, PM ;
Torrance, C ;
Waldman, T ;
Zhang, YG ;
Dillehay, L ;
Williams, J ;
Lengauer, C ;
Kinzler, KW ;
Vogelstein, B .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (03) :263-269
[9]   Requirement for p53 and p21 to sustain G2 arrest after DNA damage [J].
Bunz, F ;
Dutriaux, A ;
Lengauer, C ;
Waldman, T ;
Zhou, S ;
Brown, JP ;
Sedivy, JM ;
Kinzler, KW ;
Vogelstein, B .
SCIENCE, 1998, 282 (5393) :1497-1501
[10]  
DEOCALUNA RM, 1995, NATURE, V268, P2779